Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Veiligheid en effectiviteit van laquinimod bij Huntington
apr 2024 | Bewegingsstoornissen